Industry News
Regulatory DNA sequences responsible for diseases characterised
Scientists have developed a new system to identify and characterise the molecular components that control the activities of regulatory DNA sequences in the human genome. [ + ]
Fresh Science competition closes this week
Nominations for Fresh Science, the national competition that helps early-career researchers find, and then share, their stories of discovery, close this week. [ + ]
Oceania has the world's highest risk of rheumatic heart disease
A newly released study finds that people living in the Oceania region, including Australia, have the highest risk in the world of having and dying from rheumatic heart disease. [ + ]
Measuring metal contamination on-site
Environmental scientists have developed what they claim to be an accurate, rapid and inexpensive method for assessing metal-contaminated sites. [ + ]
UNSW to house Australia's first quantum computing company
Silicon Quantum Computing, which holds the distinction of being Australia's first harware quantum computing company, has been launched at the University of New South Wales (UNSW). [ + ]
Boehringer Ingelheim initiates Phase IIa study of liver disease drug
Boehringer Ingelheim has initiated a European and North American Phase IIa trial in non-alcoholic steatohepatitis (NASH) of investigational drug candidate BI 1467335, acquired from fellow pharma company Pharmaxis in May 2015. [ + ]
Stemina prepares to launch autism diagnostic product
As it gears up for the launch of its autism diagnostic test panel, US metabolomics company Stemina Biomarker Discovery has announced the appointment of Dr Heiner Dreismann to its board of directors. [ + ]
Clarivate Analytics selected as ERA citation provider
The Australian Research Council has announced its selection of Clarivate Analytics to provide citation information for the 2018 round of Excellence in Research for Australia (ERA), Australia's national research evaluation framework. [ + ]
QIAGEN and Clinical Genomics partner on liquid biopsy for colorectal cancer
QIAGEN has announced the implementation of the PAXgene Blood ccfDNA Tube with Clinical Genomics' Colvera colorectal cancer (CRC) recurrence assay, enabling blood to be drawn and stored for several days before testing. [ + ]
Immune system can be modulated by manipulating metabolism
Austrian researchers have revealed that such an excessive immune response can be modulated by targeted manipulation of sugar metabolism. [ + ]
Combating superbug resistance with phage therapy
Researchers have shown that bacteriophage therapy can be used successfully to treat systemic, multidrug-resistant bacterial infections. [ + ]
'Stiffer' blood vessels may increase risk of heart attack
Research led by Macquarie University has found that blood vessel 'stiffness', or distensibility, is an important determinant of blood flow, and may play a role in influencing the fate of Australians living with coronary heart disease. [ + ]
Immunotherapy for peanut allergy proves effective four years on
A treatment for deadly peanut allergy has been found to show long-lasting effects, providing what is claimed to be the strongest evidence yet that a cure may be possible for peanut allergy. [ + ]
Perth clinical research company using electronic trial data capture
Perth-based research company Linear Clinical Research is using cloud-based technology to record data on its patients and participants involved in a clinical trial. [ + ]
Young Tall Poppies recognised during National Science Week
Nine outstanding young researchers from NSW have been recognised with Young Tall Poppy Science Awards as part of the Sydney Science Festival and National Science Week. [ + ]
